1. Home
  2. FRSX vs DRMA Comparison

FRSX vs DRMA Comparison

Compare FRSX & DRMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Foresight Autonomous Holdings Ltd.

FRSX

Foresight Autonomous Holdings Ltd.

N/A

Current Price

$1.55

Market Cap

4.9M

Sector

Technology

ML Signal

N/A

Logo Dermata Therapeutics Inc.

DRMA

Dermata Therapeutics Inc.

N/A

Current Price

$1.24

Market Cap

5.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FRSX
DRMA
Founded
N/A
2014
Country
Israel
United States
Employees
N/A
9
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.9M
5.1M
IPO Year
2016
N/A

Fundamental Metrics

Financial Performance
Metric
FRSX
DRMA
Price
$1.55
$1.24
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$10.00
AVG Volume (30 Days)
1.5M
47.6K
Earning Date
05-15-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$650.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.31
$0.59
52 Week High
$3.00
$7.33

Technical Indicators

Market Signals
Indicator
FRSX
DRMA
Relative Strength Index (RSI) 36.78 44.39
Support Level $0.83 $1.13
Resistance Level $2.27 $1.40
Average True Range (ATR) 0.24 0.08
MACD -0.04 -0.01
Stochastic Oscillator 23.12 21.73

Price Performance

Historical Comparison
FRSX
DRMA

About FRSX Foresight Autonomous Holdings Ltd.

Foresight Autonomous Holdings Ltd is a technology company engaged in the development of 3D perception systems and cellular-based applications. The company designs, develops, and commercializes in-line-of-sight vision systems and beyond-line-of-sight accident prevention solutions through its subsidiaries. Its solutions are based on stereo vision, 3D perception, and V2X technologies, aimed at improving safety by enabling accurate obstacle detection and real-time alerts. The company targets multiple industries, including automotive, defense, agriculture, and heavy equipment.

About DRMA Dermata Therapeutics Inc.

Dermata Therapeutics Inc develops and commercializes dermatology products for the treatment of common skin conditions. It focuses on leveraging prior clinical and technical expertise to develop OTC treatments for conditions such as acne, psoriasis, rosacea, and seborrheic dermatitis. The company is currently developing a once-weekly acne treatment system that utilizes an active ingredient from the OTC monograph in combination with the company's Spongilla technology. It intends to apply its Spongilla technology platform across a range of dermatologic and aesthetic skin applications, including intradermal delivery of botulinum toxin. The company's operates in one segment, which is the business of developing, branding, marketing, and commercializing direct to consumer skincare products.

Share on Social Networks: